Patents Assigned to NANOGETIC S.L.
  • Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
    Patent number: 12115229
    Abstract: Disclosed is a nanoparticle system consisting of a polymer support or substrate in the form of nanoparticles to which a hydrolase enzyme able to degrade hyaluronic acid and one or more biologically and/or pharmacologically active molecules are covalently bonded, its preparation process and its uses in the diagnostic, prognostic and therapeutic fields.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: October 15, 2024
    Assignees: FIDIA FARMACEUTICI S.P.A., NANOGETIC S.L.
    Inventors: Rosario Maria Sanchez Martin, Salvatore Pernagallo, Juan Diego Unciti Broceta, Luciano Messina, Susanna Vaccaro, Laura Pilotto
  • NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSES
    Publication number: 20230056857
    Abstract: Disclosed is a nanoparticle system consisting of a polymer support or substrate in the form of nanoparticles to which a hydrolase enzyme able to degrade hyaluronic acid and one or more biologically and/or pharmacologically active molecules are covalently bonded, its preparation process and its uses in the diagnostic, prognostic and therapeutic fields.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 23, 2023
    Applicants: FIDIA FARMACEUTICI S.P.A., NANOGETIC S.L.
    Inventors: Rosario Maria SANCHEZ MARTIN, Salvatore PERNAGALLO, Juan Diego UNCITI BROCETA, Luciano MESSINA, Susanna VACCARO, Laura PILOTTO
  • Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
    Patent number: 11510995
    Abstract: Disclosed is a nanoparticle system consisting of a polymer support or substrate in the form of nanoparticles to which a hydrolase enzyme able to degrade hyaluronic acid and one or more biologically and/or pharmacologically active molecules are covalently bonded, its preparation process and its uses in the diagnostic, prognostic and therapeutic fields.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: November 29, 2022
    Assignees: FIDIA FARMACEUTICI S.P.A., NANOGETIC S.L.
    Inventors: Rosario Maria Sanchez Martin, Salvatore Pernagallo, Juan Diego Unciti Broceta, Luciano Messina, Susanna Vaccaro, Laura Pilotto
  • NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSES
    Publication number: 20180360990
    Abstract: Disclosed is a nanoparticle system consisting of a polymer support or substrate in the form of nanoparticles to which a hydrolase enzyme able to degrade hyaluronic acid and one or more biologically and/or pharmacologically active molecules are covalently bonded, its preparation process and its uses in the diagnostic, prognostic and therapeutic fields.
    Type: Application
    Filed: December 20, 2016
    Publication date: December 20, 2018
    Applicants: FIDIA FARMACEUTICI S.P.A., NANOGETIC S.L.
    Inventors: Rosario Maria SANCHEZ MARTIN, Salvatore PERNAGALLO, Juan Diego UNCITI BROCETA, Luciano MESSINA, Susanna VACCARO, Laura PILOTTO